Hjem › Multippel sklerose › New Jersey
Kliniske studier for Multippel sklerose i New Jersey
11 studier for Multippel sklerose søker deltakere på steder i New Jersey.
Byer i New Jersey
Offisiell studietekst (engelsk)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Rutgers Cancer Institute of New Jersey, New Brunswick
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Bridgewater
- TG Therapeutics Investigational Trial Site, Cherry Hill
- TG Therapeutics Investigational Trial Site, Freehold
- og 3 flere
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06433752Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Holy Name Medical Center- Site Number : 8400101, Teaneck
RekruttererFase 3
Alder 18 til 60 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07325292Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Local Institution - 0131, New Brunswick
RekruttererFase 3
Alder 10 til 17 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06408259A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice
- Novartis, East Hanover
RekruttererObservasjonsstudie
Alder 18 til 100 · Alle kjønn · Oppdatert 21. aug. 2026 · NCT07779460A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis
- Kessler Foundation, East Hanover
Rekrutterer
Alder 18 til 70 · Alle kjønn · Oppdatert 5. aug. 2026 · NCT06197685Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia
- Bristol Myers Squibb, Lawrenceville
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 29. jul. 2026 · NCT07732907Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis
- Atlantic Health, Morristown
RekruttererFase 4
Alder 18 og eldre · Kvinner · Oppdatert 29. mai 2026 · NCT07614321Multiple Sclerosis Implementation Network (Registry)
- Multiple Sclerosis Association of America, Cherry Hill
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 17. feb. 2026 · NCT07415824Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
- Kessler Foundation, West Orange
Rekrutterer
Alder 18 til 75 · Alle kjønn · Oppdatert 24. nov. 2025 · NCT04855825Testing the Feasibility of Computer-based Cognitive Training in Individuals with Multiple Sclerosis Living in the Community
- Kessler Foundation, East Hanover
Rekrutterer
Alder 19 til 65 · Alle kjønn · Oppdatert 21. feb. 2025 · NCT06608797Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.